In chronic myelogenous leukaemia (CML), p210bcr/abl1 activates RhoA leading to amoeboid migration, where inactivation of RhoA is able to reverse this process (Daubon et al., 2008). This evidence concerns the gene RHOA and chronic myelogenous leukemia, BCR-ABL1 positive.